SARS-CoV-2-induced myocarditis in pediatric patients: A 10-case series from Sanandaj, Iran: Pediatric myocarditis

Ramyar Rahimi-Darehbagh; Avat Karimi; Shirin Behzadi; Shilan Mohammadi; Behzad Khalafi; Media Babahajiani; Borhan Moradveisi

doi:10.22122/cdj.v12i1.823

Authors

Ramyar Rahimi-Darehbagh Student Research Committee, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0003-4494-4380
Avat Karimi Department of Pediatrics, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0002-9437-8471
Shirin Behzadi Department of Pediatrics, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0001-6191-7021
Shilan Mohammadi Department of Pediatrics, School of Medicine, Be’sat Teaching Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0002-2950-0119
Behzad Khalafi Health Policy Research Center, Health Research Institute, Shiraz University of Medical Sciences, Shiraz AND Virtual School, Tehran University of Medical Sciences, Tehran, Iran https://orcid.org/0000-0001-8913-0415
Media Babahajiani Student Research Committee, Vice Chancellor for Research and Technology, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0002-9308-1879
Borhan Moradveisi Department of Pediatrics, Cancer and Immunology Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran https://orcid.org/0000-0002-1952-4344

DOI:

https://doi.org/10.22122/cdj.v12i1.823

Keywords:

Myocarditis, SARS-CoV-2, Viral Infections, Pediatrics

Abstract

BACKGROUND: Fever, cough, and acute lung involvement are severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms. Children can be asymptomatic virus carriers and may contribute to the prevalence of coronavirus disease 2019 (COVID-19). Like other viral diseases, the involvement of different heart parts is also seen in this disease. Myocarditis is an inflammation of the myocardium, usually caused by a virus. The primary aim of this study is to investigate the occurrence and clinical manifestations of myocarditis among pediatric patients infected with SARS-CoV-2 in Sanandaj, Iran.

CASE REPORT: In this study, COVID-19 myocarditis cases in Be’sat Hospital, Sanandaj, were documented. Ten pediatric patients with a definitive diagnosis of COVID-19 who were admitted to Be’sat Hospital in Sanandaj in 2020 were included in this study based on clinical trials after seeking echocardiography and confirming myocarditis. The mean age of these 10 study cases was 7.1 years (2 to 13 years). The most common symptoms were fever, respiratory distress, cough, and vomiting. Ceftriaxone, intravenous immunoglobulin (IVIG), and dopamine were the main interventions in these cases. After these cases, all general practitioners and pediatricians in the province and the country were given the necessary warnings. Based on the results, COVID-19 infections, like viral infections, such as enterovirus and adenovirus, are known as the main causes of myocarditis, which appear as local or general myocardial inflammation, tissue necrosis, and ventricular dysfunction.

CONCLUSION: A direct viral attack and overactive immune responses in viral myocarditis can harm heart tissue. Therefore, in COVID-19-infected individuals, serial symptom evaluation and monitoring are necessary.

References

Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, Navaeifar MR, Enayati AA, Manafi Anari A, et al. COVID-19 infection in Iranian children: A Case series of 9 patients. J Pediatr Rev. 2020; 8(2): 139-44.

Jalalvand M, Akhtari M, Farhadi E, Mahmoudi M. Coronavirus disease 2019 (COVID-19) immunopathogenesis, diagnosis, and treatment. Iranian Journal of Biology. 2020; 4(7): 251-9.

Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020; 41(5): 102573.

Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39(7): 618-25.

Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000; 343(19): 1388-98.

Schultz JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009; 84(11): 1001-9.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020; 5(7): 831-40.

Thiele H. Cardiovascular emergencies in the COVID-19 pandemic. Herz. 2020; 45(4): 327-8.

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020; 75(18): 2352-71.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9.

Fontes JA, Rose NR, Cihakova D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine. 2015; 74(1): 62-8.

Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34(33): 2636-2648d.

Tschope C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021; 18(3): 169-93.

Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight. 2021; 6(13): e148980.

Eslami N, Aghbash PS, Shamekh A, Entezari-Maleki T, Nahand JS, Sales AJ, et al. SARS-CoV-2: Receptor and co-receptor tropism probability. Curr Microbiol. 2022; 79(5): 133.

Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6): 590-2.

Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: Current problems. Intern Emerg Med. 2021; 16(5): 1123-9.

Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J. 2021; 42(2): 206.

Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020; 48(5): 773-7.

Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, et al. Postmortem findings in Italian patients with COVID-19: A descriptive full autopsy study of cases with and without comorbidities. J Infect Dis. 2020; 222(11): 1807-15.

Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A, et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7(5): 2440-7.

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265-73.

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 819-24.

Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021; 19(1): 5-14.

Nappi F, Avtaar Singh SS. SARS-CoV-2-induced myocarditis: A state-of-the-art review. Viruses. 2023; 15(4): 916.

SARS-CoV-2-induced myocarditis in pediatric patients: A 10-case series from Sanandaj, Iran

Pediatric myocarditis

Authors

DOI:

Keywords:

Abstract

References

Downloads

Published

How to Cite

Issue

Section

License

Most read articles by the same author(s)

Editor-in-Chief

logos

isc.sid

cope

cabi

ethic

irisweb